Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2023 Dec:113:109033.
doi: 10.1016/j.ijscr.2023.109033. Epub 2023 Nov 14.

Eccrine spiradenoma of nose: Surgical case report

A D C Opango  1 , B Nshimirimana  2 , A Jaifi  2 , S Belmaachi  3 , S Fawzi  2 , N Mansouri-Hattab  4
Affiliations
Case Reports

Eccrine spiradenoma of nose: Surgical case report

A D C Opango et al. Int J Surg Case Rep. 2023 Dec.

Abstract

Introduction and importance: Eccrine spiradenoma is a benign tumor of the eccrine sweat glands, preferentially affecting the scalp, face and trunk. Few cases are described in the literature, it is a fairly rare pathology.

Presentation of the case: We present the case of a 64-year-old man who consulted for an ulcerative and nodular lesion of the left side of the nose for 5 years. He was treated in our department (excision and reconstruction). Pathological examination revealed a benign eccrine spiradenoma.

Clinical discussion: Eccrine spiradenoma is a relatively rare benign adnexal tumor. His diagnosis is based on histopathological examination. His treatment is surgical. In case of incomplete excision of the tumor, the risk of recurrence is always possible. The risk of malignant transformation exists, particularly for tumors with a long duration of evolution.

Conclusion: Benign eccrine spiradenoma is a rare adnexal tumor, but it is important to know about it. The main risk is malignant transformation.

Keywords: Benign; Case report; Eccrine spiradenoma; Excision; Reconstruction; Skin tumor.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest statement Authors of this article have no conflict or competing interests.

Figures

Fig. 1
Fig. 1
Ulceronodular lesion of the left wing of the nose.
Fig. 2
Fig. 2
CT in bone and parenchymal windows showing the ulcero-nodular lesion of the wing of the left nose.
Fig. 3
Fig. 3
Anatomopathology. A. Low magnification, well-limited dermal tumor proliferation. B. Lobular and trabecular architecture (HE ×40). C. Tumor cells rounded, variable in.
Fig. 4
Fig. 4
Before the surgery.
Fig. 5
Fig. 5
After excision of lesion.
Fig. 6
Fig. 6
Reconstruction by a frontal flap.
Fig. 7
Fig. 7
Result at 1 month post-weaning (front view).
See this image and copyright information in PMC

References

    1. Kersting D.W., Helwig E.B. Eccrine epidenoma. A.M.A. Arch. Derm. 1956;73:199–227. - PubMed
    1. Dhua S., Sekhar D.R. A rare case of eccrine spiradenoma - treatment and management. Eur. J. Plast. Surg. 2016;39:143–146. - PMC - PubMed
    1. Agha R.A., Franchi T., Sohrabi C., Mathew G., for the SCARE Group The SCARE 2020 guideline: updating consensus Surgical CAse REport (SCARE) guidelines. Int. J. Surg. 2020;84:226–230. - PubMed
    1. Kanwaljeet S., Chatterjee T. Eccrine spiradenoma: a rare adnexal tumor. Indian J. Cancer. 2017;54:695–696. - PubMed
    1. Revis P., Chyu J., Medenica M. Multiple eccrine spiradenoma: case report and review. J. Cutan. Pathol. 1988;15:226–229. - PubMed

Publication types